|Videos|September 1, 2017

Evolving Paradigms

  • Non-Small Cell Lung Cancer
  • Volume 1
  • Issue 1

Dr. Bazhenova on Considering Factors to Treat Non-Driver Patients With NSCLC With Bevacizumab

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses the factors to take into consideration when treating a patient with non-driver non–small cell lung cancer with bevacizumab (Avastin).


Latest CME